Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $494,002 (100.0% shares, 0.0% debt)

Holdings (22)

New Positions (13)

XNCR XENCOR INC 2.2%

Value ($000) $10,802 Shares 705,558 Est. Cost $14.94 Unrealized 0.0%

IMTX IMMATICS N.V 2.0%

Value ($000) $9,680 Shares 921,950 Est. Cost $10.09 Unrealized 0.0%

KRRO KORRO BIO INC 1.1%

Value ($000) $5,430 Shares 677,915 Est. Cost $23.38 Unrealized 0.0%

NEUP NEUPHORIA THERAPEUTICS INC 0.7%

Value ($000) $3,396 Shares 875,228 Est. Cost $7.10 Unrealized 0.0%

AGIO AGIOS PHARMACEUTICALS INC 0.4%

Value ($000) $2,167 Shares 79,624 Est. Cost $35.08 Unrealized 0.0%

CGON CG ONCOLOGY INC 0.3%

Value ($000) $1,312 Shares 31,591 Est. Cost $41.38 Unrealized 0.0%

ARWR ARROWHEAD PHARMACEUTICALS IN 0.2%

Value ($000) $800 Shares 12,043 Est. Cost $49.01 Unrealized 0.0%

TRDA ENTRADA THERAPEUTICS INC 0.1%

Value ($000) $531 Shares 51,689 Est. Cost $10.28 Unrealized —

HOWL WEREWOLF THERAPEUTICS INC 0.1%

Value ($000) $416 Shares 655,926 Est. Cost $1.22 Unrealized 0.0%

MPLT MAPLIGHT THERAPEUTICS INC 0.0%

Value ($000) $237 Shares 13,477 Est. Cost $16.75 Unrealized 0.0%

— GENERATION BIO CO 0.0%

Value ($000) $142 Shares 25,000 Est. Cost $5.68 Unrealized —

PRQR PROQR THRAPEUTICS N V 0.0%

Value ($000) $138 Shares 68,486 Est. Cost $2.34 Unrealized 0.0%

— APPLIED THERAPEUTICS INC 0.0%

Value ($000) $41 Shares 410,500 Est. Cost $0.10 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
XNCR	XENCOR INC	705,558	$10,802	2.2%	$14.94	0.0%	COM	98401F105
IMTX	IMMATICS N.V	921,950	$9,680	2.0%	$10.09	0.0%	SHS	N44445109
KRRO	KORRO BIO INC	677,915	$5,430	1.1%	$23.38	0.0%	COM	500946108
NEUP	NEUPHORIA THERAPEUTICS INC	875,228	$3,396	0.7%	$7.10	0.0%	COM	64136E102
AGIO	AGIOS PHARMACEUTICALS INC	79,624	$2,167	0.4%	$35.08	0.0%	COM	00847X104
CGON	CG ONCOLOGY INC	31,591	$1,312	0.3%	$41.38	0.0%	COM	156944100
ARWR	ARROWHEAD PHARMACEUTICALS IN	12,043	$800	0.2%	$49.01	0.0%	COM	04280A100
TRDA	ENTRADA THERAPEUTICS INC	51,689	$531	0.1%	$10.28	—	COM	29384C108
HOWL	WEREWOLF THERAPEUTICS INC	655,926	$416	0.1%	$1.22	0.0%	COM	95075A107
MPLT	MAPLIGHT THERAPEUTICS INC	13,477	$237	0.0%	$16.75	0.0%	COM	56565P103
—	GENERATION BIO CO	25,000	$142	0.0%	$5.68	—	COM NEW	37148K209
PRQR	PROQR THRAPEUTICS N V	68,486	$138	0.0%	$2.34	0.0%	SHS EURO	N71542109
—	APPLIED THERAPEUTICS INC	410,500	$41	0.0%	$0.10	—	COM	03828A101

Increased Positions (5)

CGEM CULLINAN THERAPEUTICS INC 18.8%

Value ($000) $92,772 (+171.3%) Shares 8,963,500 (+55.5%) Est. Cost $9.81 Unrealized -8.1%

GHRS GH RESEARCH PLC 26.8%

Value ($000) $132,164 (+26.7%) Shares 10,406,575 (+21.0%) Est. Cost $11.10 Unrealized +22.7%

DNLI DENALI THERAPEUTICS INC 5.8%

Value ($000) $28,707 (+655.5%) Shares 1,738,750 (+564.4%) Est. Cost $16.50 Unrealized +2.3%

TCRX TSCAN THERAPEUTICS INC 1.6%

Value ($000) $8,019 (-43.9%) Shares 8,019,148 (+2.1%) Est. Cost $2.30 Unrealized -37.1%

DSGN DESIGN THERAPEUTICS INC 0.1%

Value ($000) $652 (+31.3%) Shares 69,516 (+5.4%) Est. Cost $4.93 Unrealized +58.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	CULLINAN THERAPEUTICS INC	8,963,500 (+55.5%)	$92,772 (+171.3%)	18.8%	$9.81	-8.1%	COM	230031106
GHRS	GH RESEARCH PLC	10,406,575 (+21.0%)	$132,164 (+26.7%)	26.8%	$11.10	+22.7%	ORDINARY SHARES	G3855L106
DNLI	DENALI THERAPEUTICS INC	1,738,750 (+564.4%)	$28,707 (+655.5%)	5.8%	$16.50	+2.3%	COM	24823R105
TCRX	TSCAN THERAPEUTICS INC	8,019,148 (+2.1%)	$8,019 (-43.9%)	1.6%	$2.30	-37.1%	COM	89854M101
DSGN	DESIGN THERAPEUTICS INC	69,516 (+5.4%)	$652 (+31.3%)	0.1%	$4.93	+58.9%	COM	25056L103

Exited Positions (5)

— MERUS N V 29.2%

Value ($000) $144,439 Shares 1,534,141 Est. Cost $36.34 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 9.4%

Value ($000) $46,502 Shares 700,014 Est. Cost $41.90 Unrealized +95.3%

ADCT ADC THERAPEUTICS SA 1.1%

Value ($000) $5,303 Shares 1,325,848 Est. Cost $3.15 Unrealized +28.7%

IBIO IBIO INC 0.2%

Value ($000) $874 Shares 1,055,897 Est. Cost $1.47 Unrealized -7.3%

ALLO ALLOGENE THERAPEUTICS INC 0.1%

Value ($000) $677 Shares 546,119 Est. Cost $2.63 Unrealized -49.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	1,534,141	$144,439	29.2%	$36.34	—	—	N5749R100
PTGX	PROTAGONIST THERAPEUTICS INC	700,014	$46,502	9.4%	$41.90	+95.3%	—	74366E102
ADCT	ADC THERAPEUTICS SA	1,325,848	$5,303	1.1%	$3.15	+28.7%	—	H0036K147
IBIO	IBIO INC	1,055,897	$874	0.2%	$1.47	-7.3%	—	451033708
ALLO	ALLOGENE THERAPEUTICS INC	546,119	$677	0.1%	$2.63	-49.8%	—	019770106

Decreased Positions (1)

DTIL PRECISION BIOSCIENCES INC 0.8%

Value ($000) $4,135 (-28.2%) Shares 993,913 (-4.7%) Est. Cost $6.69 Unrealized -15.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DTIL	PRECISION BIOSCIENCES INC	993,913 (-4.7%)	$4,135 (-28.2%)	0.8%	$6.69	-15.1%	COM NEW	74019P207

Unchanged Positions (3)

STOK STOKE THERAPEUTICS INC 34.7%

Value ($000) $171,544 Shares 5,404,674 Est. Cost $8.00 Unrealized +276.0%

PASG PASSAGE BIO INC 1.5%

Value ($000) $7,360 Shares 623,704 Est. Cost $6.96 Unrealized +24.0%

CCCC C4 THERAPEUTICS INC 2.7%

Value ($000) $13,557 Shares 7,098,133 Est. Cost $4.48 Unrealized -47.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STOK	STOKE THERAPEUTICS INC	5,404,674	$171,544	34.7%	$8.00	+276.0%	COM	86150R107
PASG	PASSAGE BIO INC	623,704	$7,360	1.5%	$6.96	+24.0%	COM NEW	702712209
CCCC	C4 THERAPEUTICS INC	7,098,133	$13,557	2.7%	$4.48	-47.1%	COM STK	12529R107